
Intellectual Property
The staff of MolMo Services appear as inventors on many worldwide patents in disease areas ranging from virology through neurology to oncology.
MolMo Services has since its inception been set up as an intellectual property provider.
We do consider the transfer of IP an important part of our product offering.
This means that our customers can count on our assistance in protection of the IP we generate for them,
and in the filing of optimal patent applications.
But we are also well aware that IP is more than just the patent:
MolMo Services will provide the externalized knowledge associated with the IP in the form of reports,
presentations, publications, computational methods, software and software support,
and all relevant data to aid you in managing the know-how generated for your company.
Research by MolMo Services will therefore truly enhance your IP portfolio and it provides
a competitive advantage for all your research driven projects.
WO/2006/035051
A bacterial ATP Synthase binding domain
WO/2006/015985
HIV inhibiting 1,2,4-triazinone derivatives
WO/2005/028479
HIV replication inhibiting purine derivatives
WO/2004/096807
HIV Integrase inhibitors
WO/2004/074266
HIV inhibiting 1,2,4-triazines
WO/2004/074262
HIV replication inhibiting pyrimidines and triazines
WO/2004/074261
HIV replication inhibiting pyrimidines and triazines
WO/2004/069812
Pyrimidine derivatives for the prevention of HIV infection
WO/2003/037891
Heteroaryl amines as glycogen synthase kinase 3-beta inhibitors (GSK3 inhibitors)
WO/2003/037877
Aminobenzamide derivatives as glycogen synthase kinase 3-beta inhibitors
WO/2003/037869
Amide derivatives as glycogen synthase kinase 3-beta inhibitors
WO/2003/016306
HIV inhibiting pyrimidines derivatives
WO/2002/078708
HIV inhibiting pyrazinone derivatives
WO/2001/085700
HIV replication inhibiting pyrimidines and triazines
WO/2001/085699
Prodrugs of HIV replication inhibiting pyrimidines
WO/2000/027828
2,4-Disubstituted triazine derivatives with anti HIV activity
WO/2000/027825
HIV replication inhibiting pyrimidines
WO/1999/050256
Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections
WO/1999/050250
HIV inhibiting pyrimidine derivatives